Ā | Ā | pCR | non-pCR | P-value | ||
---|---|---|---|---|---|---|
Variables | Ā | n a | % b | n a | % b | Ā |
n | Ā | 57 | Ā | 77 | Ā | Ā |
Age (mean, range) | Ā | 52.8 | 26ā81 | 51.9 | 26ā79 | 0.665 |
Histologyc | NST | 53 | 93 | 76 | 99 | 0.084 |
Ā | Special type | 4 | 7 | 1 | 1 | Ā |
Tumor gradec | High | 16 | 28 | 24 | 31 | 0.980 |
Ā | Low/intermediate | 35 | 61 | 52 | 68 | Ā |
Ā | Not evaluated | 6 | 11 | 1 | 1 | Ā |
Ki67 LI (%) (mean, range)c | 61.4 | 10ā90 | 49.7 | 5ā95 | 0.009 | |
ERc | Positive | 33 | 58 | 46 | 60 | 0.830 |
Ā | Negative | 24 | 42 | 31 | 40 | Ā |
PgRc | Positive | 18 | 32 | 31 | 40 | 0.302 |
Ā | Negative | 39 | 68 | 46 | 60 | Ā |
HER2c | 3+ | 54 | 95 | 66 | 86 | 0.091 |
Ā | 2ā+āFISH+ | 3 | 5 | 11 | 14 | Ā |
Chemotherapyd | Aā+āT | 56 | 98 | 63 | 82 | 0.019 |
Ā | Ā A only | 0 | 0 | 11 | 14 | Ā |
Ā | T only | 1 | 2 | 2 | 3 | Ā |
Ā | Others | 0 | 0 | 1e | 1 | Ā |
Anti-HER2 therapyd | Tra only | 38 | 67 | 45 | 58 | 0.076 |
Ā | Traā+āPer | 8 | 14 | 5 | 6 | Ā |
Ā | None | 11 | 19 | 27 | 35 | Ā |